S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
pixel
Log in
ASX:CYP

Cynata Therapeutics Competitors

Add
Compare
Today's Range N/A
50-Day Range
A$0.68
MA: A$0.68
A$0.68
52-Week Range N/A
Volume159,853 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Cynata Therapeutics (ASX:CYP) Vs. CHV, DDXS, PREV, TNGN, COM, and MYM

Should you be buying CYP stock or one of its competitors? Companies in the industry of "biotechnology" are considered alternatives and competitors to Cynata Therapeutics, including (CHV) (CHV), (DDXS) (DDXS), (PREV) (PREV), (TNGN) (TNGN), 138267 (COM.TO) (COM), and 17031 (MYM).

(CHV) (CNSX:CHV) and Cynata Therapeutics (ASX:CYP) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Profitability

This table compares (CHV) and Cynata Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(CHV)N/AN/AN/A
Cynata TherapeuticsN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (CHV) and Cynata Therapeutics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(CHV)0000N/A
Cynata Therapeutics0000N/A

Valuation & Earnings

This table compares (CHV) and Cynata Therapeutics' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(CHV)N/AN/AN/AN/AN/A
Cynata Therapeutics$7.01 million0.00$-5,014,694.72A($0.04)N/A

(CHV) has higher earnings, but lower revenue than Cynata Therapeutics.

Summary

Cynata Therapeutics beats (CHV) on 1 of the 1 factors compared between the two stocks.

(DDXS) (OTCMKTS:DDXS) and Cynata Therapeutics (ASX:CYP) are both health technology companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Profitability

This table compares (DDXS) and Cynata Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(DDXS)N/AN/AN/A
Cynata TherapeuticsN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (DDXS) and Cynata Therapeutics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(DDXS)0000N/A
Cynata Therapeutics0000N/A

Valuation & Earnings

This table compares (DDXS) and Cynata Therapeutics' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(DDXS)N/AN/AN/AN/AN/A
Cynata Therapeutics$7.01 million0.00$-5,014,694.72A($0.04)N/A

(DDXS) has higher earnings, but lower revenue than Cynata Therapeutics.

Summary

Cynata Therapeutics beats (DDXS) on 1 of the 1 factors compared between the two stocks.

(PREV) (CNSX:PREV) and Cynata Therapeutics (ASX:CYP) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, profitability, institutional ownership, risk, dividends, valuation and earnings.

Valuation & Earnings

This table compares (PREV) and Cynata Therapeutics' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
(PREV)N/AN/AN/AN/AN/A
Cynata Therapeutics$7.01 million0.00$-5,014,694.72A($0.04)N/A

(PREV) has higher earnings, but lower revenue than Cynata Therapeutics.

Analyst Ratings

This is a breakdown of recent ratings and recommmendations for (PREV) and Cynata Therapeutics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
(PREV)0000N/A
Cynata Therapeutics0000N/A

Profitability

This table compares (PREV) and Cynata Therapeutics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
(PREV)N/AN/AN/A
Cynata TherapeuticsN/AN/AN/A

Summary

Cynata Therapeutics beats (PREV) on 1 of the 1 factors compared between the two stocks.

Cynata Therapeutics (ASX:CYP) and (TNGN) (OTCMKTS:TNGN) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.

Earnings and Valuation

This table compares Cynata Therapeutics and (TNGN)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cynata Therapeutics$7.01 million0.00$-5,014,694.72A($0.04)N/A
(TNGN)N/AN/AN/AN/AN/A

(TNGN) has lower revenue, but higher earnings than Cynata Therapeutics.

Analyst Recommendations

This is a summary of recent recommendations for Cynata Therapeutics and (TNGN), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cynata Therapeutics0000N/A
(TNGN)0000N/A

Profitability

This table compares Cynata Therapeutics and (TNGN)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cynata TherapeuticsN/AN/AN/A
(TNGN)N/AN/AN/A

Summary

Cynata Therapeutics beats (TNGN) on 1 of the 1 factors compared between the two stocks.

Cynata Therapeutics (ASX:CYP) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.

Earnings and Valuation

This table compares Cynata Therapeutics and 138267 (COM.TO)'s revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cynata Therapeutics$7.01 million0.00C$-5,014,694.72A($0.04)N/A
138267 (COM.TO)N/AN/AN/AN/AN/A

138267 (COM.TO) has lower revenue, but higher earnings than Cynata Therapeutics.

Analyst Recommendations

This is a summary of recent recommendations for Cynata Therapeutics and 138267 (COM.TO), as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cynata Therapeutics0000N/A
138267 (COM.TO)0000N/A

Profitability

This table compares Cynata Therapeutics and 138267 (COM.TO)'s net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cynata TherapeuticsN/AN/AN/A
138267 (COM.TO)N/AN/AN/A

Summary

Cynata Therapeutics beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.

Cynata Therapeutics (ASX:CYP) and 17031 (CNSX:MYM) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.

Earnings and Valuation

This table compares Cynata Therapeutics and 17031's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cynata Therapeutics$7.01 million0.00C$-5,014,694.72A($0.04)N/A
17031N/AN/AN/AN/AN/A

17031 has lower revenue, but higher earnings than Cynata Therapeutics.

Analyst Recommendations

This is a summary of recent recommendations for Cynata Therapeutics and 17031, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Cynata Therapeutics0000N/A
170310000N/A

Profitability

This table compares Cynata Therapeutics and 17031's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Cynata TherapeuticsN/AN/AN/A
17031N/AN/AN/A

Summary

Cynata Therapeutics beats 17031 on 1 of the 1 factors compared between the two stocks.


Cynata Therapeutics Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
CHV
(CHV)
0.5N/AN/A$0.00N/A0.00High Trading Volume
(DDXS) logo
DDXS
(DDXS)
0.5$0.00flat$0.00N/A0.00
PREV
(PREV)
0.7N/AN/A$0.00N/A0.00High Trading Volume
TNGN
(TNGN)
0.4N/AN/A$0.00N/A0.00Gap Up
COM
138267 (COM.TO)
0.5N/AN/AC$0.00N/A0.00
MYM
17031
0.4N/AN/AC$0.00N/A0.00
4BB
4basebio UK Societas
0.3N/AN/A£0.00N/A0.00Insider Buying
News Coverage
Gap Down
ATTBF
Abattis Bioceuticals
0.4$0.02flat$0.00N/A0.00Gap Up
Abzena plc (ABZA.L) logo
ABZA
Abzena plc (ABZA.L)
0.6$15.75flat£0.00N/A0.00
ACR
Acrux
0.9N/AN/A$0.00$1.25 million0.00High Trading Volume
News Coverage
Gap Up
ACW
Actinogen Medical
0.5N/AN/A$0.00$3.52 million0.00High Trading Volume
Gap Up
1AD
AdAlta
0.5N/AN/A$0.00$3.83 million0.00High Trading Volume
News Coverage
Gap Up
ADTX
ADiTx Therapeutics
1.0$3.03flat$0.00N/A0.00
AHZ
Admedus
0.5N/AN/A$0.00N/A0.00High Trading Volume
AGNPF
Algernon Pharmaceuticals
0.0$0.28flat$0.00N/A0.00Gap Down
LBTSF
Almirall
0.5$12.40flat$0.00N/A0.00
AMBS
Amarantus BioScience
0.5N/AN/A$0.00N/A0.00High Trading Volume
ATX
Amplia Therapeutics
0.8N/AN/A$0.00$894,155.000.00High Trading Volume
Gap Up
ANR
Anatara Lifesciences
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Up
ANVS
Annovis Bio
0.0N/AN/A$0.00N/A0.00High Trading Volume
CBDC
Apotheca Biosciences
0.4$0.02flat$0.00N/A0.00Gap Up
ARNI
Arno Therapeutics
0.5$0.00flat$0.00N/A0.00
ASCLF
Ascletis Pharma
0.4$0.37flat$0.00N/A0.00
CDMOP
Avid Bioservices
0.3$29.60flat$0.00N/A0.00
AXIM
AXIM Biotechnologies
0.4$0.65flat$0.00N/A0.00
BXRXV
Baudax Bio
0.5N/AN/A$0.00N/A0.00High Trading Volume
BRRGF
BerGenBio ASA
0.7$3.88flat$0.00N/A0.00
BGT
Bio-Gene Technology
0.5N/AN/A$0.00$82,795.000.00High Trading Volume
Gap Up
BNO
Bionomics Limited (BNO.AX)
0.5N/AN/A$0.00$3.19 million0.00High Trading Volume
Gap Up
BIT
Biotron
0.5N/AN/A$0.00$853,026.000.00High Trading Volume
Gap Up
BXN
Bioxyne
0.5N/AN/A$0.00$2.32 million0.00High Trading Volume
Gap Up
BOT
Botanix Pharmaceuticals
0.5N/AN/A$0.00$7.56 million0.00High Trading Volume
Gap Up
BPH
BPH Energy
0.5N/AN/A$0.00$240,243.000.00High Trading Volume
Gap Up
BTC
BTC Health Limited (BTC.AX)
0.5N/AN/A$0.00$131,934.000.00High Trading Volume
News Coverage
Gap Up
CNBX
Cannabics Pharmaceuticals
0.4$0.43flat$0.00N/A0.00News Coverage
Gap Up
ORHOF
CannaRoyalty
0.7$9.23flat$0.00N/A0.00Gap Down
CDXI
Cardax
0.0N/AN/A$0.00N/A0.00High Trading Volume
CDY
Cellmid Limited (CDY.AX)
0.8N/AN/A$0.00$6.61 million0.00High Trading Volume
Gap Up
CBBT
Cerebain Biotech
0.0$0.14flat$0.00N/A0.00
CGYG
China Longyi Group International
0.4$0.00flat$0.00N/A0.00
CLVLY
Clinuvel Pharmaceuticals
1.0$16.95flat$0.00N/A0.00
CUV
Clinuvel Pharmaceuticals
0.6N/AN/A$0.00$32.57 million0.00High Trading Volume
Gap Up
CELZ
Creative Medical Technology
0.5$0.05flat$0.00N/A0.00Gap Down
CSL Limited (CSL.AX) logo
CSL
CSL Limited (CSL.AX)
0.8N/AN/A$0.00$9.98 billion0.00Dividend Cut
High Trading Volume
Gap Up
CLXPF
Cybin
1.0$1.27flat$0.00N/A0.00
CURE
Direxion Daily Healthcare Bull 3X Shares
0.5N/AN/A$0.00N/A0.00High Trading Volume
Gap Down
ETBI
Eastgate Biotech
0.5$0.00flat$0.00N/A0.00
EMMBF
Emblem
0.6$1.40flat$0.00N/A0.00News Coverage
ENZC
Enzolytics
0.0$0.60flat$0.00N/A0.00
EX1
Exopharm
0.6N/AN/A$0.00$2.67 million0.00High Trading Volume
Gap Up
This page was last updated on 2/27/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.